QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Flores, C. Articles by Stewart, J. Search for Related Content PubMed PubMed Citation Articles by Flores, C. Articles by Stewart, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB AMPHETAMINE GLUTAMIC ACID HYDROCHLORIDE

 Previous Article  |  Next Article 

The Journal of Neuroscience, 2000, 20:RC55:1-5

RAPID COMMUNICATION
Requirement of Endogenous Basic Fibroblast Growth Factor for Sensitization to Amphetamine

Cecilia Flores, Anne-Noël Samaha, and Jane Stewart

Center for Studies in Behavioral Neurobiology Department of Psychology, Concordia University, Montreal, Quebec H3G 1M8, Canada

Repeated exposure to amphetamine produces long-lasting increases in sensitivity to its effects. We reported previously that repeated amphetamine treatment results in increased astrocytic expression of basic fibroblast growth factor (bFGF) in the ventral tegmental area (VTA) and substantia nigra compacta (SNc) and that this effect is prevented by coadministration of a nonspecific glutamate receptor antagonist. Here we show that the development of sensitization to amphetamine is prevented when amphetamine injections are preceded by infusions of a neutralizing antibody to bFGF into the VTA. In addition, we show that astrocytic bFGF expression is increased in the VTA and SNc of animals that exhibit behavioral sensitization and that the number of bFGF-immunoreactive astrocytes in these regions is strongly and positively correlated with the magnitude of sensitization. Cotreatment with an NMDA glutamate receptor antagonist blocks both the development of behavioral sensitization and bFGF induction. These results show that endogenous bFGF is necessary for the development of sensitization to amphetamine and suggest that bFGF mediates the glutamatergic-dopaminergic interaction that initiates the long-term consequences of repeated drug use.

Key words: basic fibroblast growth factor; bFGF; FGF-2; neurotrophic factors; amphetamine; sensitization; dopamine; glutamate; NMDA

---

Copyright © 2000 Society for Neuroscience  0270-6474/00/$05.00/0

This article has been cited by other articles:

				C. M. Papadopoulos, S.-Y. Tsai, V. Guillen, J. Ortega, G. L. Kartje, and W. A. Wolf Motor Recovery and Axonal Plasticity With Short-Term Amphetamine After Stroke Stroke, January 1, 2009; 40(1): 294 - 302. [Abstract] [Full Text] [PDF]

				J. Stewart Psychological and neural mechanisms of relapse Phil Trans R Soc B, October 12, 2008; 363(1507): 3147 - 3158. [Abstract] [Full Text] [PDF]

				A. Nakajima, K. Yamada, T. Nagai, T. Uchiyama, Y. Miyamoto, T. Mamiya, J. He, A. Nitta, M. Mizuno, M. H. Tran, et al. Role of Tumor Necrosis Factor-{alpha} in Methamphetamine-Induced Drug Dependence and Neurotoxicity J. Neurosci., March 3, 2004; 24(9): 2212 - 2225. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help